Short answer
LifeMD, Inc. (LFMD) filed an 8-K current report with the SEC on August 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). LifeMD reported financial results for Q2 and first six months ended June 30, 2026.
LifeMD, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- LifeMD reported financial results for Q2 and first six months ended June 30, 2026
- Exhibit 99.1 contains the substantive results investors need to assess revenue, profitability, and outlook
Item 7.01 · Regulation FD Disclosure
- Investor presentation furnished as Exhibit 99.2 for meetings beginning August 5, 2026
- Presentation may be modified and is also available on LifeMD’s website
- Forward-looking content covers industry growth, company growth rates, and future cash flow
- Investors should evaluate projections alongside SEC filings and stated risk factors
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $47.3M, down 4% YoY, while adjusted EBITDA swung to a $3.5M loss from $3.9M profit
- Full-year guidance sharply reduced to $205.5M–$212.5M revenue and negative $6.0M to breakeven adjusted EBITDA
- Gross margin expanded to 89% from 86%; recurring subscriptions reached 84% of revenue, supporting revenue visibility
- Active subscribers grew 20% to approximately 356,000, including approximately 108,000 weight management subscribers
- Cash $25.1M, no debt, and $30M undrawn revolver provide liquidity while management targets positive adjusted EBITDA in the second half of 2026
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other LifeMD, Inc. 8-K filings
Get the next LFMD 8-K as it lands
Follow LFMD for push alerts, or ask the research agent what this filing means.